Vertex Pharmaceuticals

NASDAQ: VRTX · Real-Time Price · USD
394.23
3.93 (1.01%)
At close: Aug 15, 2025, 12:38 PM

Vertex Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-535.6M 3.62B 3.32B 2.34B
Depreciation & Amortization
207.2M 181.3M 148.3M 125.6M
Stock-Based Compensation
698.5M 581.2M 491.3M 441.4M
Other Working Capital
52.3M 92.6M 715M 230.4M
Other Non-Cash Items
900K -42.6M 103.4M -5.8M
Deferred Income Tax
-348.8M -536.5M -275.9M -154.6M
Change in Working Capital
-514.8M -265.7M 340.8M -105.2M
Operating Cash Flow
-492.6M 3.54B 4.13B 2.64B
Capital Expenditures
-297.7M -258.4M -204.7M -235M
Cash Acquisitions
n/a n/a -295.9M 77M
Purchase of Investments
-7.7B -3.79B -692.7M -605.2M
Sales Maturities Of Investments
4.47B 934.2M 920M 499.3M
Other Investing Acitivies
-241.7M -89M -47.8M -77M
Investing Cash Flow
-3.77B -3.14B -321.1M -340.9M
Debt Repayment
-33.6M -44.9M -82M -18.7M
Common Stock Repurchased
-1.58B -653.7M -172M -1.56B
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
120.8M 136.4M 186.3M 102M
Financial Cash Flow
-1.49B -562.2M -67.7M -1.48B
Net Cash Flow
-5.8B -139.7M 3.71B 811.2M
Free Cash Flow
-790.3M 3.28B 3.93B 2.41B